Jubilant Ingrevia Limited (NSE:JUBLINGREA) Analysts Are Pretty Bullish On The Stock After Recent Results

Last week saw the newest yearly earnings release from Jubilant Ingrevia Limited (NSE:JUBLINGREA), an important milestone in the company's journey to build a stronger business. It looks like the results were a bit of a negative overall. While revenues of ₹42b were in line with analyst predictions, statutory earnings were less than expected, missing estimates by 4.0% to hit ₹15.84 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

We check all companies for important risks. See what we found for Jubilant Ingrevia in our free report.

After the latest results, the three analysts covering Jubilant Ingrevia are now predicting revenues of ₹47.1b in 2026. If met, this would reflect a notable 12% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to bounce 27% to ₹20.15. Before this earnings report, the analysts had been forecasting revenues of ₹48.7b and earnings per share (EPS) of ₹20.87 in 2026. The analysts are less bullish than they were before these results, given the reduced revenue forecasts and the small dip in earnings per share expectations.

Check out our latest analysis for Jubilant Ingrevia

What's most unexpected is that the consensus price target rose 5.1% to ₹918, strongly implying the downgrade to forecasts is not expected to be more than a temporary blip. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on Jubilant Ingrevia, with the most bullish analyst valuing it at ₹1,150 and the most bearish at ₹735 per share. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

Of course, another way to look at these forecasts is to place them into context against the industry itself. It's pretty clear that there is an expectation that Jubilant Ingrevia's revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 12% growth on an annualised basis. This is compared to a historical growth rate of 17% over the past five years. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 13% annually. Factoring in the forecast slowdown in growth, it looks like Jubilant Ingrevia is forecast to grow at about the same rate as the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. They also downgraded their revenue estimates, although as we saw earlier, forecast growth is only expected to be about the same as the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At Simply Wall St, we have a full range of analyst estimates for Jubilant Ingrevia going out to 2028, and you can see them free on our platform here..

You can also view our analysis of Jubilant Ingrevia's balance sheet, and whether we think Jubilant Ingrevia is carrying too much debt, for free on our platform here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.